United States Neurostimulation Devices Market to Grow at 11.1% CAGR, Reaching USD 7.82 Billion by 2033, Led by Medtronic, Abbott, and Boston Scientific | DataM Intelligence

The global Neurostimulation Devices Market reached USD 6.99 billion in 2024 and is projected to reach USD 7.82 billion by 2033, growing at a CAGR of 11.1% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments

✅ In October 2023, Medtronic received FDA approval for its next-generation spinal cord stimulation system with adaptive stimulation technology.
✅ In October 2023, Abbott Laboratories launched its new InfinityTM deep brain stimulation system with directional lead technology in the U.S. market.
✅ In October 2023, Boston Scientific Corporation initiated a pivotal clinical trial for its novel vagus nerve stimulation system for treatment-resistant depression.

Europe: Recent Industry Developments

✅ In October 2023, Siemens Healthineers partnered with a leading European research institution to develop AI-powered neuromodulation therapies.
✅ In October 2023, The European Commission approved €200 million in funding for advanced neurostimulation research through Horizon Europe program.
✅ In October 2023, LivaNova PLC expanded its VNS Therapy® System manufacturing capacity in Europe to meet growing demand for epilepsy treatment.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/neurostimulation-devices-market?jd

Market Trends & Drivers

The Neurostimulation Devices Market is experiencing rapid growth driven by the increasing prevalence of neurological disorders, technological advancements in minimally invasive devices, and growing acceptance of neuromodulation therapies. Key trends include the development of closed-loop systems, miniaturization of devices, and integration of artificial intelligence for personalized therapy. The aging population, rising healthcare expenditure, and expanding applications in chronic pain management are significantly accelerating market demand across all neurostimulation segments.

Competitive Landscape

The market features intense competition among medical device giants and specialized neuromodulation companies.

Medtronic plc leads the market with its comprehensive portfolio of spinal cord stimulation, deep brain stimulation, and sacral neuromodulation systems.
Abbott Laboratories dominates in deep brain stimulation and spinal cord stimulation with its InfinityTM and ProclaimTM platforms.
Boston Scientific Corporation maintains strong presence with its WaveWriterTM and PrecisionTM spinal cord stimulation systems.
Nevro Corp. specializes in high-frequency spinal cord stimulation technology for chronic pain management.
LivaNova PLC focuses on vagus nerve stimulation systems for epilepsy and depression treatment.
NeuroPace, Inc. leads in responsive neurostimulation systems for epilepsy patients.
DJO Global, Inc. provides peripheral nerve stimulation systems for chronic pain conditions.
Synapse Biomedical, Inc. specializes in diaphragm pacing systems for respiratory conditions.
Axonics Modulation Technologies, Inc. focuses on sacral neuromodulation systems for urinary dysfunction.
Saluda Medical Pty Ltd develops novel closed-loop spinal cord stimulation technology.

Segmentation

By Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices, Non-Invasive Brain & Peripheral Stimulators, Others)
By Application (Pain Management, Epilepsy, Parkinson's Disease & Movement Disorders, Depression & Psychiatric Indications, Migraine & Cluster Headache, Sleep Disorders, Others)
By End-User (Hospitals, Specialty/Neurology Clinics, Ambulatory Surgical Centers, Rehabilitation Centers, Academic and Research Institutes, Others)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/neurostimulation-devices-market?jd

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (Germany, U.K., France, Italy, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a market research and consulting firm that bridges the gap between data and decisive action. We specialize in translating top market trends and in-depth analysis into swift, smart solutions for your business.
With a repository of 6,300+ reports across 40+ industries, we provide the robust intelligence that over 200 companies in 50+ countries rely on to power their growth.

This release was published on openPR.